 Asian Scientist Magazine | SciClone Licenses Chronic Heart Failure Drug From Zensun Asian Scientist Magazine Chronic heart failure has a large underlying patient base in China of approximately five million urban patients. It is expected that the prevalence of CHF in China will increase to over seven million urban patients over the next ten years, primarily ... China Biotech In Review: SciClone Pharma In-Licenses China Rights To Heart ... |
